J 2024

Generation of human induced pluripotent stem cell lines from patients with a RYR2 gene variant c.14201A>G (p.Y4734C): Implications for idiopathic ventricular fibrillation and catecholaminergic polymorphic ventricular tachycardia

ÇELIKER, Canan; Štefan ZELENÁK; Samuel LIETAVA; Jiří PACHERNÍK; Markéta BÉBAROVÁ et. al.

Basic information

Original name

Generation of human induced pluripotent stem cell lines from patients with a RYR2 gene variant c.14201A>G (p.Y4734C): Implications for idiopathic ventricular fibrillation and catecholaminergic polymorphic ventricular tachycardia

Edition

Stem cell research, Amsterdam, Elsevier, 2024, 1873-5061

Other information

Language

English

Type of outcome

Article in a journal

Field of Study

10601 Cell biology

Country of publisher

Netherlands

Confidentiality degree

is not subject to a state or trade secret

References:

Impact factor

Impact factor: 0.700

RIV identification code

RIV/00216224:14110/24:00137190

Organization unit

Faculty of Medicine

UT WoS

001302477700001

EID Scopus

2-s2.0-85201767014

Keywords in English

human induced pluripotent stem cell lines; RYR2

Tags

International impact, Reviewed
Changed: 26/3/2025 13:04, Mgr. Tereza Miškechová

Abstract

In the original language

Human induced pluripotent stem cell (iPSC) lines were generated from peripheral blood mononuclear cells (PBMCs) isolated from two related patients diagnosed with either idiopathic ventricular fibrillation or catecholaminergic polymorphic ventricular tachycardia, carrying an unknown variant in the RYR2 gene, c.14201A>G (p.Y4734C) and one healthy related individual. Reprogramming was done using a commercially available Epi5 Reprogramming Kit. The pluripotency of the iPSC lines was verified by the expression of pluripotency markers and by their capacity to differentiate into all three embryonic germ layers in vitro. These iPSC lines are available for functional analysis and in vitro studies of RYR2 channelopathy.

Links

MUNI/A/1598/2023, interní kód MU
Name: Zdroje pro tkáňové inženýrství 14
Investor: Masaryk University, Resources pro tissue engineering 14
NU22-02-00348, research and development project
Name: Funkční hodnocení genetických variant u případů klinicky „skutečné“ idiopatické fibrilace komor: in vitro a in silico modelování s cílem odhalit arytmogenní mechanismus
Investor: Ministry of Health of the CR, Subprogram 1 - standard